News

KJ Muldoon was born with a devastating medical problem. Racing to solve it, doctors may have launched a 'roadmap' for a new type of treatment.
As pet insurance coverage increases and consumers demand higher standards of care, the veterinary dermatology drugs market is set to grow steadily. INDORE, INDIA, May 21, 2025 /EINPresswire.com/ -- ...
Amid volatile trade and rising uncertainty, these momentum stocks have shown strong signs of leadership in the first half of ...
especially if patients are planning to use the medications long term. Adverse events should be reported to the FDA’s MedWatch program. MPR, a trusted source of medical news and feature content ...
The U.S. FDA is removing concentrated fluoride prescription drugs for children from the market. Unlike fluoride toothpaste or rinses, which are consumed by infants and toddlers, these products ...
In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...
FDA approved Merck's Welireg as the first oral therapy for advanced pheochromocytoma or paraganglioma (PPGL). In the LITESPARK-015 trial, Welireg showed a 26% ORR and a 20.4-month median duration ...
New FDA Leadership Team: The FDA's top leadership has shifted under Commissioner Dr. Marty Makary, with Dr. Vinayak "Vinay" Prasad now heading the Center for Biologics Evaluation and Research ...
The FDA is reviewing the BLA for clesrovimab to ... Similar efficacy was observed between the 2 medications; the incidence of RSV-associated disease and hospitalizations were 3.6% and 1.3% ...
The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.
"I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth," the FDA's Commissioner of Food and Drugs ...